activity
20082026
most citedAlternative Analysis Methods for Time to Event Endpoints under Non-proportional Hazards: A Comparative Analysis

112 citations · 264 across the 17 of their papers we have counts for

collaborators
Showing 2022Show all

1 paper · 1 filter

stat.ME2022★ 9 cited

Duration of and time to response in oncology clinical trials from the perspective of the estimand framework

Hans-Jochen Weber, Stephen Corson, Jiang Li +6

Duration of response (DOR) and time to response (TTR) are typically evaluated as secondary endpoints in early-stage clinical studies in oncology when efficacy is assessed by the be…